Last reviewed · How we verify
Liposomal Bupivacaine 13.3
Liposomal Bupivacaine 13.3 is a Small molecule drug developed by Pacira Pharmaceuticals, Inc. It is currently in Phase 1 development.
At a glance
| Generic name | Liposomal Bupivacaine 13.3 |
|---|---|
| Sponsor | Pacira Pharmaceuticals, Inc |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Liposomal Bupivacaine With Standard Bupivacaine Versus Dexmedetomidine With Standard Bupivacaine (PHASE3)
- Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations (PHASE4)
- Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine (NA)
- The Use of Pecs Blocks in Combination With Exparel in Breast Reconstruction Surgery (PHASE3)
- Liposomal Bupivacaine and Transoral Robotic Surgery
- The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics (PHASE4)
- Phase 1, Dose Escalation Study to Evaluate of Safety, Pharmacokinetics and Pharmacodynamics of Liposomal Bupivacaine 13.3 Administered Via a Single Intrathecal Injection to Healthy Volunteers (PHASE1)
- Liposomal Bupivacaine in One-level Instrumented Posterior Spinal Fusion (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Liposomal Bupivacaine 13.3 CI brief — competitive landscape report
- Liposomal Bupivacaine 13.3 updates RSS · CI watch RSS
- Pacira Pharmaceuticals, Inc portfolio CI
Frequently asked questions about Liposomal Bupivacaine 13.3
What is Liposomal Bupivacaine 13.3?
Liposomal Bupivacaine 13.3 is a Small molecule drug developed by Pacira Pharmaceuticals, Inc.
Who makes Liposomal Bupivacaine 13.3?
Liposomal Bupivacaine 13.3 is developed by Pacira Pharmaceuticals, Inc (see full Pacira Pharmaceuticals, Inc pipeline at /company/pacira-pharmaceuticals-inc).
What development phase is Liposomal Bupivacaine 13.3 in?
Liposomal Bupivacaine 13.3 is in Phase 1.
Related
- Manufacturer: Pacira Pharmaceuticals, Inc — full pipeline
- Compare: Liposomal Bupivacaine 13.3 vs similar drugs
- Pricing: Liposomal Bupivacaine 13.3 cost, discount & access